Vaccine Update: Pfizer asks FDA for emergency use of its COVID-19 shot

Pfizer, Vaccine

US drugmaker Pfizer Inc, which has developed a 95 per cent effective vaccine against coronavirus, is now seeking the emergency use tag from the US government for its dosage. Pfizer has said the emergency use tag could start the process early and the coronavirus vaccine doses could be available as early as next month.

Now its on the US Food and Drug Administration to decide if there’s enough evidence to allow emergency vaccinations. If so, first supplies will be scarce and rationed. Experts warn it likely will be spring before there’s enough for everyone.

On Wednesday, Pfizer said the final results of its ongoing coronavirus vaccine trials have suggested that the Pfizer coronavirus vaccine shots are 95% effective, a month after the first dose was administered.

Pfizer said on Friday it is asking US regulators to allow emergency use of its Covid-19 vaccine.

The application to the FDA comes just days after Pfizer and German partner BioNTech SE reported final trial results that showed the vaccine was 95% effective in preventing Covid-19 with no major safety concerns.

(With inputs from agencies)

LEAVE A REPLY

Please enter your comment!
Please enter your name here